| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 4,914,489 shares worth roughly $168.8M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.12B | - | |
| 10% | 34.49M | $1.25B | - | |
| Pres | 18.68M | $678.74M | - | |
| CEO | 16.74M | $608.19M | - | |
| Dir | 13.69M | $497.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2022 | Gline Matthew | CEO | Sell | 35,386 | $5.06 | $179,053.16 | -2.3% | -6.4% | +39.0% | |
| Mar 25, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 7,281 | $5.06 | $36,841.86 | -4.2% | -6.4% | +39.0% | |
| Mar 18, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 2,153 | $5.13 | $11,044.89 | -1.2% | -26.4% | +67.6% | |
| Mar 18, 2022 | Gline Matthew | CEO | Sell | 82,006 | $5.13 | $420,690.78 | -5.2% | -26.4% | +67.6% | |
| Mar 7, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 3,091 | $5.52 | $17,062.32 | -1.7% | -26.2% | +51.9% | |
| Mar 7, 2022 | Gline Matthew | CEO | Sell | 92,324 | $5.52 | $509,628.48 | -5.5% | -26.2% | +51.9% | |
| Sep 4, 2020 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 380,000 | $33.00 | $12,540,000.00 | +0.8% | - | - | |
| Apr 16, 2020 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 1,034,483 | $14.50 | $15,000,003.50 | +2.8% | - | - | |
| Feb 24, 2020 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 5,333,333 | $3.75 | $19,999,998.75 | +40.3% | - | - | |
| Dec 27, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Sell | 22,860,013 | $0.00 | - | -100% | - | - |